Ullman Anders has filed 12 insider transactions across 1 company since April 2024.
Most recent transaction: a disposition of 64000 shares of Verona Pharma plc ($VRNA) on October 07, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Ordinary Shares | 358856 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.05% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | M | Ordinary Shares | 24000 | $0.00 | 358,856.0000 | 727,223,000 | 7.17% | 0.00% |
| April 25, 2025 | Verona Pharma plc | $VRNA | Ullman Anders | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 29, 2024 | Verona Pharma plc | $VRNA | Ullman Anders | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |